How long does olanzapine remain in the body after a single dose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Olanzapine Half-Life and Duration in the Body

Olanzapine has a half-life ranging from 21 to 54 hours (mean of 30 hours), meaning it takes approximately 5-7 days (about 5-7 half-lives) for the drug to be essentially eliminated from your body after the last dose. 1

Pharmacokinetic Timeline

After a single oral dose of olanzapine:

  • Peak concentration: Reached in approximately 6 hours 1
  • Elimination half-life: 21-54 hours (5th to 95th percentile), with a mean of 30 hours 1
  • Steady-state: Achieved in about 1 week with daily dosing, with concentrations approximately twice those after single doses 1
  • Time to elimination: Approximately 5-7 days (150-210 hours) for near-complete clearance

Metabolism and Excretion

Olanzapine is extensively metabolized before elimination:

  • Only 7% excreted unchanged in urine 1
  • 57% recovered in urine (as metabolites) 1
  • 30% recovered in feces 1
  • Primary metabolic pathways involve direct glucuronidation and CYP1A2-mediated oxidation 1

Factors Affecting Duration

The half-life and clearance vary significantly between individuals based on:

  • Gender: Women have lower clearance than men 1
  • Smoking status: Smokers have higher clearance (CYP1A2 induction) 1
  • Age: Elderly patients may have reduced clearance 1
  • Hepatic function: Minimal impact in mild-moderate impairment 1
  • Renal function: Minimal impact since only 7% excreted unchanged 1

Clinical Pearl: The apparent plasma clearance ranges from 12 to 47 L/hr (5th to 95th percentile, mean of 25 L/hr), representing up to a 4-fold variability between individuals 1. This wide range explains why some patients may experience effects for longer periods than others.

Intramuscular Formulation

For intramuscular olanzapine:

  • Peak concentrations: Within 15-45 minutes 1
  • Half-life: Similar to oral administration 1
  • The elimination timeline remains approximately 5-7 days after the last injection

References

Related Questions

Can olanzapine be initiated in a child with an unclear clinical picture while awaiting serology results?
What is the appropriate olanzapine dose for children, including age and weight‑based recommendations?
Is a 50 mg dose of olanzapine safe for an adult patient?
Can increasing the dose of olanzapine (Zyprexa) cause agitation in a patient?
Can olanzapine be prescribed for children, and what are the appropriate age range, dosing guidelines, and safety monitoring recommendations?
In a patient with heterozygous ADRA2A C/G and COMT val/val genotype, which stimulant—methylphenidate or amphetamine—is preferred for treating attention-deficit/hyperactivity disorder?
What are the typical symptoms of intermittent claudication?
What is the onset of action of Rexulti (brexpiprazole) and how should sedation be managed during its titration?
Is it safe to use a long‑acting β2‑agonist (LABA) together with a short‑acting β2‑agonist (SABA) without an inhaled corticosteroid?
What does an elevated C-reactive protein with a normal erythrocyte sedimentation rate indicate in a wound‑care patient?
What is the pathophysiology of an acute COPD exacerbation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.